Technical guide
How to Calculate the Lithium Dose for Prelithiation
Prelithiation stands or falls on the dose. The calculation itself is straightforward; the difficulty is that every input has to come from the electrode actually being used, and that the result has to be confirmed rather than assumed.
In short
The dose is dimensioned against the irreversible first-cycle capacity of the specific electrode: measure that capacity per unit area, express it as the equivalent lithium charge, and add it as an areal dose. Because uniformity and losses between treatment and assembly are never perfect, the calculated value is a starting point that has to be verified in cells.
Step 1 — Measure the irreversible capacity
Cycle the real electrode once under the formation protocol you intend to use and record first-charge and first-discharge capacity. The difference is the irreversible capacity; divided by the electrode area it becomes the areal irreversible capacity, typically expressed in mAh/cm².
Everything downstream depends on this number, so it has to be measured on the final electrode formulation, loading and calendering state, with the intended electrolyte, cut-off voltages, rate and temperature. Changing any of these changes the dose.
Step 2 — Convert to a lithium dose
The areal irreversible capacity is a charge, and prelithiation has to deliver an equivalent amount of lithium per unit area. In an electrochemical route this converts directly into a current-time product, which is why that route is convenient for establishing a reference dose.
For chemical, direct-contact and additive routes the delivered lithium is not measured directly. There the same target dose has to be translated into process settings — reagent concentration and exposure time, contact time and pressure, or additive loading — and that translation is established by calibration, not by calculation alone.
Step 3 — Decide how much margin to allow
Compensating exactly the measured irreversible capacity is the natural target, but real processes lose some of the added lithium between treatment and cell assembly, and the distribution over the electrode area is never perfectly even.
Both directions carry risk, which is why the dose window is normally explored rather than fixed on the first attempt.
- Under-dosing leaves part of the first-cycle loss uncompensated
- Over-dosing risks metallic lithium on the anode surface and its safety consequences
- Local over-dosing can occur even at a correct average dose if distribution is uneven
- Storage time and atmosphere between treatment and assembly consume part of the dose
Step 4 — Verify in cells
A dose is only validated by the cell result. The direct check is the first-cycle coulombic efficiency of a full cell built with the prelithiated electrode, compared against an untreated reference from the same electrode batch.
A dose series — several levels around the calculated value, otherwise identical — is usually more informative than a single point, because it shows both where compensation becomes complete and where the process starts to over-lithiate. Cycling beyond formation is needed as well, since a dose that looks ideal in the first cycle can still be wrong for cycle life.
What makes dosage results comparable
Dosage work generates numbers that are only meaningful together with their conditions. Recording them consistently is what allows two trials, or two methods, to be compared at all.
- Electrode formulation, areal loading and porosity
- Target areal dose and the actual process settings used to deliver it
- Time and atmosphere between treatment and cell assembly
- Electrolyte, formation protocol, rate, temperature and voltage limits
- Untreated reference from the same electrode batch
Key points
- Dimension the dose against the measured areal irreversible capacity of the real electrode.
- Non-electrochemical routes need calibration, because the delivered lithium is not measured directly.
- Under-dosing leaves loss uncompensated; over-dosing risks metallic lithium.
- Validate with a dose series and an untreated reference, and cycle beyond formation.